Epidemiology of Mycobacterium avium complex disease

American Journal of Medicine

Volumn 102, Issue 5 C, 1997, Pages 11-15

  Horsburgh Jr , C Robert ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CERVICAL LYMPH NODE; CLINICAL FEATURE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG DISEASE; LYMPHADENITIS; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0343907185     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00038-7     Document Type: Article

References (68)

1. Horsburgh CR Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med. 324:1991;1332-1338.
2. du Moulin GC, Stottmeier KD, Pelletier PA, Tsang AY, Hedley-Whyte J. Concentration of Mycobacterium avium by hospital hot water systems. JAMA. 260:1988;1599-1601.
3. von Reyn CF, Maslow JN, Barber TW, Falkinham III JO, Arbeit RD. Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet. 343:1994;1137-1141.
4. Schulze-Röbbecke R, Feldmann C, Fischeder R, Janning B, Exner M, Wahl G. Dental units: an environmental study of sources of potentially pathogenic mycobacteria. Tuber Lung Dis. 76:1995;318-323.
5. Eaton T, Falkinham III JO, von Reyn CF. Recovery of Mycobacterium avium from cigarettes. J Clin Microbiol. 33:1995;2757-2758.
6. Livingston RA, Siberry GK, Paidas CN, Eiden J. Appendicitis due to Mycobacterium avium complex in an adolescent infected with the human immunodeficiency virus. (Letter.) Clin Infect Dis. 20:1995;1579-1580.
7. Disla E, Reddy A, Cuppari G, Mullen M. Primary Mycobacterium avium complex septic arthritis in a patient with AIDS. (Letter.) Clin Infect Dis. 20:1995;1432-1434.
8. Hellinger WC, Smilack JD, Greider JL Jr, et al. Localized soft-tissue infections with Mycobacterium avium/Mycobacterium intracellulare complex in immunocompetent patients: granulomatous tenosynovitis of the hand or wrist. Clin Infect Dis. 21:1995;65-69.
9. Chin DP, Hopewell PC, Yajko DM, et al. Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection. J Infect Dis. 169:1994;289-295.
10. Horsburgh CR Jr, Mason III UG, Farhi DC, Iseman MD, Mason UG. Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature. Medicine. 64:1985;36-48.
11. Jones JL, Hanson DL, Chu SY, Fleming PL, Hu DJ, Ward JW. Surveillance of AIDS-defining conditions in the United States. Adult/Adolescent Spectrum of HIV Disease Project Group. AIDS. 8:1994;1489-1493.
12. Nightingale SD, Byrd LT, Southern PM, Jockush JD, Cal SX, Wynne BA. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis. 165:1992;1082-1085.
13. Nightingale SD, Cameron DW, Gordin FM, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med. 329:1993;828-833.
14. Pierce M, Crampton S, Henry D, et al. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med. 335:1996;384-391.
15. Horsburgh CR Jr, Chin DP, Yajko DM, et al. Environmental risk factors for acquisition of Mycobacterium avium complex in persons with human immunodeficiency virus infection. J Infect Dis. 170:1994;362-367.
16. Yajko DM, Chin DP, Gonzalez PC, et al. Mycobacterium avium complex in water, food, and soil samples collected from the environment of HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol. 9:1995;176-182.
17. von Reyn CF, Arbeit RD, Tosteson AN, et al. The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. AIDS. 10:1996;1025-1032.
18. Finkelstein DM, Williams PL, Molenberghs G, et al. Patterns of opportunistic infections in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 12:1996;38-45.
19. Horsburgh CR Jr, Hanson DL, Jones JL, Thompson SE. Protection from Mycobacterium avium complex disease in human immunodeficiency virus-infected persons with a history of tuberculosis. J Infect Dis. 174:1996;1212-1217.
20. Horsburgh CR Jr, Selik RM. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis. 139:1989;4-7.
21. Horsburgh CR Jr, Caldwell MB, Simonds RJ. Epidemiology of disseminated nontuberculous mycobacterial disease in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J. 12:1993;219-222.
22. Hoover DR, Graham NM, Bacellar H, et al. An epidemiologic analysis of Mycobacterium avium complex disease in homosexual men infected with human immunodeficiency virus type 1. Clin Infect Dis. 20:1995;1250-1258.
23. Horsburgh CR Jr, Schoenfelder JR, Gordin FM, Cohn DL, Sullam PM, Wynne BA. Geographic and seasonal variation in M. avium bacteremia among North American patients with AIDS. Am J Med Sci. 1997; in press.
24. Horsburgh CR Jr. Epidemiology of human disease caused by Mycobacterium avium complex. Can J Infect Dis. 5:((suppl B)):1994;5B-9B.
25. Okello DO, Sewankambo N, Goodgame R, et al. Absence of bacteremia with Mycobacterium avium-intracellulare in Ugandan patients with AIDS. J Infect Dis. 162:1990;208-210.
26. Gilks CF, Brindle RJ, Mwachari C, et al. Disseminated Mycobacterium avium infection among HIV-infected patients in Kenya. J Acquir Immune Defic Syndr Hum Retrovirol. 8:1995;195-198.
27. Greenberg AE, Lucas S, Tossou O, et al. Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Côte d'Ivoire. AIDS. 9:1995;1251-1254.
28. Frederick T, Caldwell B, Mascola L. Trends in pediatric AIDS-defining conditions in the USA. (Abstr. We.C3445.) 11th International Conference on AIDS, Vancouver, British Columbia: 1996.
29. Horsburgh CR Jr, Havlik JA, Ellis DA, et al. Survival of patients with acquired immune deficiency syndrome disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy. Am Rev Respir Dis. 144:1991;557-559.
30. Jacobson MA, Hopewell PC, Yajko DM, et al. Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis. 164:1991;994-998.
31. Horsburgh CR Jr, Metchock B, Gordon SM, Havlik JA Jr, McGowan JE Jr, Thompson III SE. Predictors of survival in patients with AIDS and disseminated Mycobacterium avium complex disease. J Infect Dis. 170:1994;573-577.
32. Kerlikowske KM, Katz MH, Chan AK, Perez-Stable EJ. Antimycobacterial therapy for disseminated Mycobacterium avium complex infection in patients with acquired immunodeficiency syndrome. Arch Intern Med. 152:1992;813-817.
33. Ives DV, Davis RB, Currier JS. Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated Mycobacterium avium complex. AIDS. 9:1995;261-266.
34. Shafran SD, Singer J, Zarowny DP, et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. N Engl J Med. 335:1996;377-383.
35. Teirstein AS, Damsker B, Kirschner PA, Krellenstein DJ, Robinson B, Chuang MT. Pulmonary infection with Mycobacterium avium-intracellulare: diagnosis, clinical patterns, treatment. (Clinical Conference.) Mt Sinai J Med. 57:1990;209-215.
36. Ahn CH, Ahn SS, Anderson RA, Murphy DT, Mammo A. A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex. Am Rev Respir Dis. 134:1986;438-441.
37. Etzkorn ET, Aldarondo S, McAllister CK, Matthews J, Ognibene AJ. Medical therapy of Mycobacterium avium-intracellulare pulmonary disease. Am Rev Respir Dis. 134:1986;442-445.
38. Horsburgh CR Jr, Mason III UG, Heifets LB, Southwick K, Labrecque J, Iseman MD. Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing. Am Rev Respir Dis. 135:1987;418-421.
39. Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease. Incidence, presentation, and response to therapy in a community setting. Am Rev Respir Dis. 143:1991;1381-1385.
40. Kalayjian RC, Toossi Z, Tomashefski JF Jr, et al. Pulmonary disease due to infection by Mycobacterium avium complex in patients with AIDS. Clin Infect Dis. 20:1995;1186-1194.
41. Guthertz LS, Damsker B, Bottone EJ, Ford EG, Midura TF, Janda JM. Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. J Infect Dis. 160:1989;1037-1041.
42. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis. 135:1987;1007-1014.
43. Tsukamura M, Kita N, Shimoide H, Arakawa H, Kuze A. Studies on the epidemiology of nontuberculous mycobacteriosis in Japan. Am Rev Respir Dis. 137:1988;1280-1284.
44. Debrunner M, Salfinger M, Brandli O, von Graevenitz A. Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis. 15:1992;330-345.
45. Prince DS, Peterson DD, Steiner RM, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med. 321:1989;863-868.
46. Wickman K. Clinical significance of nontuberculous mycobacteria. A bacteriological survey of Swedish strains isolated between 1973 and 1981. Scand J Infect Dis. 18:1986;337-345.
47. Iseman MD, Buschman DL, Ackerson LM. Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis. 144:1991;914-916.
48. Gruft H, Katz J, Blanchard DC. Postulated source of Mycobacterium intracellulare (Battey) infection. Am J Epidemiol. 102:1975;311-318.
49. Parker BC, Ford MA, Gruft H, Falkinham III JO. Epidemiology of infection by nontuberculous mycobacteria. IV. Preferential aerosolization of Mycobacterium intracellulare from natural waters. Am Rev Respir Dis. 128:1983;652-656.
50. Tomashefski JF Jr, Stern RC, Demko CA, et al. Nontuberculous mycobacteria in cystic fibrosis. Am J Respir Crit Care Med. 154:1996;523-528.
51. Whittier S, Hopfer RL, Knowles MR, Gilligan PH. Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol. 31:1993;861-864.
52. Kilby JM, Gilligan PH, Yankaskas JR, Highsmith WE Jr, Edwards LJ, Knowles MR. Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest. 102:1992;70-75.
53. Pinto-Powell R, Olivier KN, Marsh BJ, et al. Skin testing with Mycobacterium avium sensitin to identify infection with M. avium complex in patients with cystic fibrosis. Clin Infect Dis. 22:1996;560-562.
54. Witty LA, Tapson VF, Piantadosi CA. Isolation of mycobacteria in patients with pulmonary alveolar proteinosis. Medicine. 73:1994;103-109.
55. Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis. 20:1995;954-963.
56. Schaad UB, Votteler TP, McCracken GH Jr, Nelson JD. Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. J Pediatr. 95:1979;356-360.
57. Margileth AM, Chandra R, Altman RP. Chronic lymphadenopathy due to mycobacterial infection. Clinical features, diagnosis, histopathology, and management. Am J Dis Child. 138:1984;917-922.
58. Saitz EW. Cervical lymphadenitis caused by atypical mycobacteria. Pediatr Clin North Am. 28:1981;823-829.
59. Llewelyn DM, Dorman D. Mycobacterial lymphadenitis. Aust Paediatr J. 7:1971;98-102.
60. Grange JM, Yates MD, Pozniak A. Bacteriologically confirmed non-tuberculous mycobacterial lymphadenitis in southeast England: a recent increase in the number of cases. Arch Dis Child. 72:1995;516-517.
61. Chapman JS. The atypical mycobacteria. Hosp Pract. 5:1970;69-80.
62. Trnka L, Dankova D, Svandova E. Six years' experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex. Tuber Lung Dis. 75:1994;348-352.
63. Katila ML, Brander E, Backman A. Neonatal BCG vaccination and mycobacterial cervical adenitis in childhood. Tubercle. 68:1987;291-296.
64. Romanus V, Hallander HO, Wahlen P, Olinder-Nielsen AM, Magnusson PH, Juhlin I. Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage. Tuber Lung Dis. 76:1995;300-310.
65. Ostroff SM, Spiegel RA, Feinberg J, Benson CA, Horsburgh CR Jr. Preventing disseminated Mycobacterium avium complex disease in patients infected with human immunodeficiency virus. Clin Infect Dis. 21:((suppl 1)):1995;S72-S76.
66. Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med. 124:1996;633-642.
67. Grange JM. Is the incidence of AIDS-associated Mycobacterium avium-intracellulare disease affected by previous exposure to BCG, M. tuberculosis or environmental mycobacteria? Tuber Lung Dis. 75:1994;234-236.
68. Kallenius G, Hoffner SE, Svenson SB. Does vaccination with bacille Calmette-Guerin protect against AIDS? Rev Infect Dis. 11:1989;349-351.